Good-guy bacteria may help cancer immunotherapies do their job. Individuals with certain types of bacteria in their gut may be more likely to respond well to cancer immunotherapy, researchers found in a study of patients with metastatic melanoma. Source 1n.
New biomarkers predict outcome of cancer immunotherapy. Researchers have identified biomarkers in the blood that make it possible to predict whether cancer patients will respond positively to immunotherapy. Patients for whom therapy does not work can thus be treated using different methods at an earlier stage. Source 2v.